Improving CAR-T cell function through a targeted cytokine delivery system utilizing car target-modified extracellular vesicles
{{output}}
Chimeric antigen receptor (CAR)-T-cell therapy has achieved remarkable clinical success in the treatment of B-cell malignancies; however, its efficacy can be limited by poor T-cell persistence and insufficient antitumor activity in certain cases. Moreover, int... ...
